β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis

Cited by (758)

Items 401–500 of 758

1. Cancer upregulated gene (CUG)2 elevates YAP1 expression, leading to enhancement of epithelial-mesenchymal transition in human lung cancer cells
   Sirichat Kaowinn, Natpaphan Yawut, Sang Seok Koh, Young-Hwa Chung · 2019 · Biochemical and Biophysical Research Communications
2. The vitamin D receptor regulates miR-140-5p and targets the MAPK pathway in bone development
   Wenting Luo, Lingli Liu, Liping Yang, Yaping Dong, Tianjing Liu, Xiaowei Wei, Dan Liu, Hui Gu, Juan Kong, Zhengwei Yuan et al. · 2018 · Metabolism
3. R‐spondin 2 Drives Liver Tumor Development in a Yes‐Associated Protein‐Dependent Manner
   Caitlin B. Conboy, Germán L. Vélez‐Reyes, Barbara R. Tschida, Hsiangyu Hu, Gabriel Kaufmann, Nicholas Koes, Bryant J. Keller, Clara Alsinet, Helena Cornellà, Roser Pinyol et al. · 2019 · Hepatology Communications
4. The Hippo Pathway Effector YAP1 Regulates Intestinal Epithelial Cell Differentiation
   Sepideh Fallah, Jean‐François Beaulieu · 2020 · Cells
5. Crosstalk between hypoxia-sensing ULK1/2 and YAP-driven glycolysis fuels pancreatic ductal adenocarcinoma development
   Yu Jia, Huiyan Li, Ying Wang, Jue Wang, Jingwen Zhu, Yanyan Wei, Lou Lu, Xing Chen, Shi‐Jing Mo · 2021 · International Journal of Biological Sciences
6. Overexpression of T-box Transcription Factor 5 (TBX5) Inhibits Proliferation and Invasion in Non-Small Cell Lung Carcinoma Cells
   Ruoting Ma, Yu Pu Yang, Qiuyun Tu, Ke Hu · 2017 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
7. FGF8 promotes cell proliferation and resistance to EGFR inhibitors via upregulation of EGFR in human hepatocellular carcinoma cells
   Yuanmin Pei, Xueling Sun, Xiwei Guo, Hua-shan Yin, Le Wang, Fugu Tian, Hongxi Jing, Xiaobo Liang, Jun Xu, Pengcheng Shi · 2017 · Oncology Reports
8. Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer
   Ming‐Jenn Chen, Yaochen Wang, De‐Wei Wu, Chi-Yi Chen, Huei Lee · 2019 · Pathology - Research and Practice
9. LINC00689 participates in proliferation, chemoresistance and metastasis via miR-31-5p/YAP/β-catenin axis in colorectal cancer
   Yongliang Du, Yan Liang, Guang-Qing Shi, Yan Wei Cao, Juan Qiu, Yuan Li, Zhong Yong, Le Liu, Jian Li · 2020 · Experimental Cell Research
10. A Driver Never Works Alone—Interplay Networks of Mutant p53, MYC, RAS, and Other Universal Oncogenic Drivers in Human Cancer
    Maria Grzes, Magdalena Oroń, Zuzanna Staszczak, Akanksha Jaiswar, Magdalena Nowak-Niezgoda, Dawid Walerych · 2020 · Cancers
11. TGF-β-induced activation of conjunctival fibroblasts is modulated by FGF-2 and substratum stiffness
    Tomoyo Matsumura, Tomokazu Fujimoto, Akiko Futakuchi, Yuji Takihara, Fumika Watanabe-Kitamura, Eri Takahashi, Miyuki Inoue-Mochita, Hidenobu Tanihara, Toshihiro Inoue · 2020 · PLoS ONE
12. Targeting Hippo pathway: A novel strategy for Helicobacter pylori-induced gastric cancer treatment
    Yunyun Liu, Bingkai Zhang, Yimin Zhou, Yuanxin Xing, Yunshan Wang, Yanfei Jia, Duanrui Liu · 2023 · Biomedicine & Pharmacotherapy
13. Tyrosine phosphorylation-mediated YAP1-TFAP2A interactions coordinate transcription and trastuzumab resistance in HER2+ breast cancer
    Hailin Zou, Juan Luo, Yibo Guo, Liang Deng, Leli Zeng, Yihang Pan, Peng Li · 2024 · Drug Resistance Updates
14. An optogenetic method for interrogating YAP1 and TAZ nuclear–cytoplasmic shuttling
    Anna M. Dowbaj, Robert P. Jenkins, Daniel Williamson, John M. Heddleston, Alessandro Ciccarelli, Todd L. Fallesen, Klaus M. Hahn, Reuben D. O’Dea, John R. King, Marco Montagner et al. · 2021 · Journal of Cell Science
15. Aberrant activation, nuclear localization, and phosphorylation of yes-associated protein-1 in the embryonic kidney and Wilms tumor
    Andrew Jackson Murphy, Janene M. Pierce, Christian R. de Caestecker, Jaime M. Libes, David Neblett, Mark P. deCaestecker, Alan O. Perantoni, Shunsuke Tanigawa, James Robert Anderson, Jeffrey S. Dome et al. · 2013 · Pediatric Blood & Cancer
16. Long noncoding RNA DUXAP8 regulates proliferation and apoptosis of ovarian cancer cells via targeting miR-590-5p
    Qingyou Meng, Zhongliang Li, Jiaxue Pan, Xiaorong Sun · 2020 · Human Cell
17. Polyomavirus Small t Antigen Interacts with Yes-Associated Protein To Regulate Cell Survival and Differentiation
    Justin H. Hwang, Arun T. Pores‐Fernando, Nathalie Faure, Shaida Andrabi, William C. Hahn, Brian S. Schaffhausen, Thomas M. Roberts · 2014 · Journal of Virology
18. Cytokinesis Failure Leading to Chromosome Instability in v-Src-Induced Oncogenesis
    Yuji Nakayama, Shuhei Soeda, Masayoshi Ikeuchi, Keiko Kakae, Naoto Yamaguchi · 2017 · International Journal of Molecular Sciences
19. YAP1 is essential for tumor growth and is a potential therapeutic target for EGFR-dependent lung adenocarcinomas
    Ting‐Fang Lee, Yu-Chi Tseng, Wei‐Chin Chang, Yi‐Chen Chen, Yu-Rung Kao, Teh‐Ying Chou, Chao‐Chi Ho, Cheng‐Wen Wu · 2017 · Oncotarget
20. Ascl2 activation by YAP1/KLF5 ensures the self-renewability of colon cancer progenitor cells
    Xiaolong Wei, Jun Ye, Yangyang Shang, Haoyuan Chen, Shanxi Liu, Li Liu, Rongquan Wang · 2017 · Oncotarget
21. Scribble sub-cellular localization modulates recruitment of YES1 to regulate YAP1 phosphorylation
    Zhao, Dongyu, Yin, Zhangyuan, Soellner, Matthew B., Martin, Brent R. · 2021 · Cell Chemical Biology
22. Primary cilia and cancer: a tale of many faces
    Rebecca S. Collinson, Barbara E. Tanos · 2025 · Oncogene
23. Modeling mesothelioma utilizing human mesothelial cells reveals involvement of phospholipase-C beta 4 in YAP-active mesothelioma cell proliferation
    tatsuo kakiuchi., Taishi Takahara, Yumiko Kasugai, Kotaro Arita, Noriaki Yoshida, Kennosuke Karube, Miyuki Suguro, Keitaro Matsuo, Hayao Nakanishi, Tohru Kiyono et al. · 2016 · Carcinogenesis
24. Aspirin attenuates YAP and β-catenin expression by promoting β-TrCP to overcome docetaxel and vinorelbine resistance in triple-negative breast cancer
    Ji Ma, Zhenhai Fan, Qiulin Tang, Hongwei Xia, Tao Zhang, Feng Bi · 2020 · Cell Death and Disease
25. Desmoglein‐3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells
    Usama Sharif Ahmad, Eric Kenneth Parkinson, Hong Wan · 2022 · Molecular Oncology
26. Signaling by the tyrosine kinase Yes promotes liver cancer development
    Jean‐Philippe Guégan, Marjorie Lapouge, Laure Voisin, Marc K. Saba-El-Leil, Pierre‐Luc Tanguay, Kim Lévesque, Jérémy Brégeon, Anne‐Marie Mes‐Masson, Daniel Lamarre, Benjamin Haibe‐Kains et al. · 2022 · Science Signaling
27. How Phosphofructokinase-1 Promotes PI3K and YAP/TAZ in Cancer: Therapeutic Perspectives
    Luca Simula, Marco Alifano, Philippe Icard · 2022 · Cancers
28. Epidermal YAP2-5SA-ΔC Drives β-Catenin Activation to Promote Keratinocyte Proliferation in Mouse Skin In Vivo
    Bassem Akladios, Veronica Mendoza‐Reinoso, Michael Susithiran Samuel, Edna C. Hardeman, Kiarash Khosrotehrani, Brian Key, Annemiek Beverdam · 2016 · Journal of Investigative Dermatology
29. Hippo vs. Crab: tissue‐specific functions of the mammalian Hippo pathway
    Miki Nishio, Tomohiko Maehama, Hiroki Goto, Keisuke Nakatani, Wakako Kato, Hirofumi Omori, Yosuke Miyachi, Hideru Togashi, Yohei Shimono, Akira Suzuki · 2017 · Genes to Cells
30. Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ
    Paraskevi Xekouki, Emily J. Lodge, Jakob Matschke, Alice Santambrogio, John Richard Apps, Ariane Sharif, Thomas S. Jacques, Simon J B Aylwin, Vincent Prévot, Ran Li et al. · 2018 · Endocrine Related Cancer
31. The Hippo pathway: Horizons for innovative treatments of peripheral nerve diseases
    M. Laura Feltri, Michael R. Weaver, Sophie Belin, Yannick Poitelon · 2021 · Journal of the Peripheral Nervous System
32. Pharmacological regulators of Hippo pathway: Advances and challenges of drug development
    Zhaobai Lao, Xin Chen, Bin Pan, Bin Fang, Wanlei Yang, Yu Qian · 2025 · The FASEB Journal
33. Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non‑small lung cancer cells by regulating the YAP pathway
    Dan Jin, Yan Wu, Cuijie Shao, Yong Gao, Deqiang Wang, Jiwei Guo · 2018 · Oncology Reports · Retracted
34. Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis
    Ana Hipólito, Filipa Martins, Cindy Mendes, Filipa Lopes‐Coelho, Jacinta Serpa · 2021 · Frontiers in Oncology
35. Hippo-YAP signaling in digestive system tumors.
    Feng Yin, Jixin Dong, Liang‐I Kang, Xiuli Liu · 2021 · PubMed Central
36. Loss of HOXA10 causes endometrial hyperplasia progressing to endometrial cancer
    Anuradha Mishra, Nirmalya Ganguli, Subeer S. Majumdar, Deepak N. Modi · 2022 · Journal of Molecular Endocrinology
37. The T-box transcription factor 3 is a promising biomarker and a key regulator of the oncogenic phenotype of a diverse range of sarcoma subtypes
    Willmer, T, Cooper, A, Sims, D, Govender, D, Prince, S · 2016 · Oncogenesis
38. YES oncogenic activity is specified by its SH4 domain and regulates RAS/MAPK signaling in colon carcinoma cells.
    Fanny Dubois, Cédric Leroy, Valérie Simon, Christine Bénistant, Serge Roche · 2015 · Europe PMC (PubMed Central)
39. A mouse SWATH-MS reference spectral library enables deconvolution of species-specific proteomic alterations in human tumour xenografts
    Lukáš Krásný, Philip J. Bland, Jessica Burns, Nadia Carvalho Lima, Peter T. Harrison, Laura Pacini, Mark L. Elms, Jian Ning, Víctor G. Martínez, Yi-Ru Yu et al. · 2020 · Disease Models & Mechanisms
40. Expression of YAP1 and pSTAT3-S727 and their prognostic value in glioma
    Wei Sang, Jing Xue, Li-Ping Su, Gulinar Abulajiang, Qian Wang, Yang-Yang Zhai, Yanran Hu, Haixia Gao, Xinxia Li, Qiao-Xing Li et al. · 2020 · Journal of Clinical Pathology
41. Hippo Activation in Arrhythmogenic Cardiomyopathy
    Yong Wu Hu, William T. Pu · 2014 · Circulation Research
42. PIN1 facilitates ubiquitin-mediated degradation of serine/threonine kinase 3 and promotes melanoma development via TAZ activation
    Garam Kim, Poshan Yugal Bhattarai, Sung‐Chul Lim, Jin Young Kim, Hong Seok Choi · 2020 · Cancer Letters
43. Spatiotemporal model of cellular mechanotransduction via Rho and YAP
    Javor K. Novev, Mathias Luidor Heltberg, Mogens H. Jensen, Amin Doostmohammadi · 2021 · Integrative Biology
44. TROP2 Represents a Negative Prognostic Factor in Colorectal Adenocarcinoma and Its Expression Is Associated with Features of Epithelial–Mesenchymal Transition and Invasiveness
    Jiří Švec, Monika Šťastná, Lucie Janečková, Dušan Hrčkulák, Martina Vojtěchová, Jakub Onhajzer, Vı́tězslav Křı́ž, Kateřina Galušková, Eva Šloncová, Jan Kubovčiak et al. · 2022 · Cancers
45. A Community Challenge for Inferring Genetic Predictors of Gene Essentialities through Analysis of a Functional Screen of Cancer Cell Lines
    M. Gönen, B. Weir, G. Cowley, F. Vazquez, Y. Guan, A. Jaiswal, Masayuki Karasuyama, V. Uzunangelov, Tao Wang, Aviad Tsherniak et al. · 2017 · Cell Systems
46. Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer
    Sun Young Yim, Jae‐Jun Shim, Ji‐Hyun Shin, Yun Seong Jeong, Sanghee Kang, Sang-Bae Kim, Young‐Gyu Eun, Dong Jin Lee, Elizabeth A. Conner, Valentina M. Factor et al. · 2018 · Molecular Cancer Research
47. Elevated MST1 leads to apoptosis via depletion of YAP1 in cardiomyocytes exposed to high glucose
    Su, Dongmei, Li, Yanhua, Guan, Lina, Li, Qian, Shi, Cuige, Ma, Xu, Song, Yonghui · 2021 · Molecular Medicine
48. Lappaol F, an anticancer agent, inhibits YAP via transcriptional and post-translational regulation
    Xiao Li, Yi‐Ying Lin, Jia-Yi Tan, Kang‐Lun Liu, Xiaoling Shen, Yingjie Hu, Ruiyi Yang · 2021 · Pharmaceutical Biology
49. Emerging roles for the YAP/TAZ transcriptional regulators in brain tumour pathology and targeting options
    Dimitrios Strepkos, Mariam Markouli, Kostas A. Papavassiliou, Athanasios G. Papavassiliou, Christina Piperi · 2021 · Neuropathology and Applied Neurobiology
50. YAP1 and PRDM14 converge to promote cell survival and tumorigenesis
    Mi‐Ju Kim, Seav Huong Ly, Yingtian Xie, Gina N. Duronio, Dane Ford-Roshon, Justin H. Hwang, Rita Sulahian, Jonathan P. Rennhack, Jonathan So, Ole V. Gjoerup et al. · 2022 · Developmental Cell
51. Yes-Associated Protein and Transcriptional Coactivator with PDZ-Binding Motif in Cardiovascular Diseases
    Ruojun Li, Weiqiang Huang · 2023 · International Journal of Molecular Sciences
52. Oncogenic signaling-mediated regulation of chromatin during tumorigenesis
    Jahangir Alam, Md Nazmul Huda, Alan J. Tackett, Sayem Miah · 2023 · Cancer and Metastasis Reviews
53. Emerging Roles of YES1 in Cancer: The Putative Target in Drug Resistance
    Eunjin Kook, Kyung‐Soo Chun, Do‐Hee Kim · 2024 · International Journal of Molecular Sciences
54. Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation
    Ying-Wei Li, Jin Guo, He Shen, Jun Li, Nuo Yang, Costa G. Frangou, Kayla E. Wilson, Yinglong Zhang, Ashley L. Mussell, Marius Sudol et al. · 2016 · Cell Cycle
55. v-Src-induced nuclear localization of YAP is involved in multipolar spindle formation in tetraploid cells
    Keiko Kakae, Masayoshi Ikeuchi, Takahisa Kuga, Youhei Saito, Naoto Yamaguchi, Yuji Nakayama · 2016 · Cellular Signalling
56. Deregulation and Therapeutic Potential of the Hippo Pathway in Cancer
    Kimberly C. Lin, Hyun Woo Park, Kun‐Liang Guan · 2017 · Annual Review of Cancer Biology
57. Adaptive Resistance to Chemotherapy, A Multi–FAK-torial Linkage
    Kristin N. Taylor, David D. Schlaepfer · 2018 · Molecular Cancer Therapeutics
58. The versatile hippo pathway in oral-maxillofacial development and bone remodeling
    Lin Xiang, Hui Yu, Xinyuan Zhang, Bin Wang, Ying Yuan, Qin Zhang, Rui Ye, Ping Gong, Yingying Wu · 2018 · Developmental Biology
59. Molecular evidence of field cancerization initiated by diabetes in colon cancer patients
    Laura del Puerto‐Nevado, Pablo Mínguez, Marta Cortón, Sonia Solanes Casado, I. Prieto, Sebastián Mas, Ana Belen Sanz, Paula Gónzález-Alonso, Cristina Villaverde, Sergio Portal‐Núñez et al. · 2019 · Molecular Oncology
60. YAP/TAZ affects the development of pulmonary fibrosis by regulating multiple signaling pathways
    Ting Zhu, Zhifeng Ma, Haiyong Wang, Xiaoxiao Jia, Yuanlin Wu, Linhai Fu, Zhupeng Li, Chu Zhang, Guangmao Yu · 2020 · Molecular and Cellular Biochemistry
61. Noncanonical IL6 Signaling-Mediated Activation of YAP Regulates Cell Migration and Invasion in Ovarian Clear Cell Cancer
    Walid J. Azar, Elizabeth L. Christie, Thomas J. Mitchell, David S. Liu, George Au‐Yeung, David D.L. Bowtell · 2020 · Cancer Research
62. miR-550-1 functions as a tumor suppressor in acute myeloid leukemia via the hippo signaling pathway
    Chao Hu, Mengxia Yu, Chenying Li, Yungui Wang, Xia Li, Bryan C. Ulrich, Rui Jun Su, Lei Dong, Hengyou Weng, Huilin Huang et al. · 2020 · International Journal of Biological Sciences
63. Inhibition of β-catenin signalling promotes DNA damage elicited by benzo[a]pyrene in a model of human colon cancer cells via CYP1 deregulation
    Markéta Kabátková, Ondřej Zapletal, Zuzana Tylichová, Jiřı́ Neča, Miroslav Machala, Alena Milcová, Jan Topinka, Alois Kozubı́k, Jan Vondráček · 2015 · Mutagenesis
64. The 2016 John J. Abel Award Lecture: Targeting the Mechanical Microenvironment in Cancer
    Hannah E. Majeski, Jing Yang · 2016 · Molecular Pharmacology
65. Yes-Associated Protein 1 as a Novel Prognostic Biomarker for Gastrointestinal Cancer: A Meta-Analysis
    Luo Zhang, Xing Song, Xiaodong Li, Changping Wu, Jingting Jiang · 2018 · BioMed Research International
66. DLC1 deficiency and YAP signaling drive endothelial cell contact inhibition of growth and tumorigenesis
    Lisa Ritchey, Taekyu Ha, Atsushi Otsuka, Kenji Kabashima, Dunrui Wang, Yuyi Wang, Douglas R. Lowy, Giovanna Tosato · 2019 · Oncogene
67. Self-Sustained Regulation or Self-Perpetuating Dysregulation: ROS-dependent HIF-YAP-Notch Signaling as a Double-Edged Sword on Stem Cell Physiology and Tumorigenesis
    Chin‐Lin Guo · 2022 · Frontiers in Cell and Developmental Biology
68. Hepatic stellate cell stearoyl co-A desaturase activates leukotriene B4 receptor 2 - β-catenin cascade to promote liver tumorigenesis
    Sonal Sinha, Satoka Aizawa, Yasuhiro Nakano, Alexander Rialdi, Hye Yeon Choi, Rajan Shrestha, Stephanie Q. Pan, Yibu Chen, Meng Li, Audrey Kapelanski‐Lamoureux et al. · 2023 · Nature Communications
69. Application Of Small Molecules Favoring Naïve Pluripotency during Human Embryonic Stem Cell Derivation
    Margot Van der Jeught, Jasin Taelman, Galbha Duggal, Sabitri Ghimire, Sylvie Lierman, Susana M. Chuva de Sousa Lopes, Dieter L. D. Deforce, Tom Deroo, Petra De Sutter, Björn Heindryckx · 2015 · Cellular Reprogramming
70. STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury
    Mitsuhiko Abe, Takafumi Yoshida, Jun Akiba, Yu Ikezono, Fumitaka Wada, Atsutaka Masuda, Takahiko Sakaue, Toshimitsu Tanaka, Hideki Iwamoto, Toru Nakamura et al. · 2017 · World Journal of Gastroenterology
71. miR‑205 targets YAP1 and inhibits proliferation and invasion in thyroid cancer cells
    Dewei Li, Qiang Wang, Ning Li, Shuilong Zhang · 2018 · Molecular Medicine Reports
72. Yap1 promotes the survival and self-renewal of breast tumor initiating cells via inhibiting Smad3 signaling
    Jianguo Sun, Xiewan Chen, Luping Zhang, Jiang Wang, Max Diehn · 2015 · Oncotarget
73. Cell contact and pressure control of YAP localization and clustering revealed by super-resolution imaging
    Jing Gao, Lingli He, Yan Chao Shi, Mingjun Cai, Haijiao Xu, Junguang Jiang, Lei Zhang, Hongda Wang · 2017 · Nanoscale
74. The CK1α Activator Pyrvinium Enhances the Catalytic Efficiency (kcat/Km) of CK1α
    Chen Shen, Bin Li, Luisana Astudillo, Murray P. Deutscher, Melanie H. Cobb, Anthony J. Capobianco, Ethan N. Lee, David J. Robbins · 2019 · Biochemistry
75. P2RY6 Has a Critical Role in Mouse Skin Carcinogenesis by Regulating the YAP and β-Catenin Signaling Pathways
    Peng Xu, Caibing Wang, Wan Qin Xiang, Yiyi Liang, Ying Li, Xilin Zhang, Chunyuan Guo, Mingyao Liu, Yuling Shi, Xiyun Ye et al. · 2022 · Journal of Investigative Dermatology
76. Hippo in Gastric Cancer: From Signalling to Therapy
    Lornella Seeneevassen, Pierre R. Dubus, Caroline Gronnier, Christine Varon · 2022 · Cancers
77. Transcriptional activity mediated by β-CATENIN and TCF/LEF family members is completely dispensable for survival and propagation of multiple human colorectal cancer cell lines
    Janna Fröhlich, Katja Rose, Andreas Hecht · 2023 · Scientific Reports
78. Context-dependent T-BOX transcription factor family: from biology to targeted therapy
    Siwen Li, Xiangyuan Luo, Mengyu Sun, Yijun Wang, Zerui Zhang, Junqing Jiang, Dian Hu, Jiaqian Zhang, Zhangfan Wu, Yufei Wang et al. · 2024 · Cell Communication and Signaling
79. Introducing STRaNDs: shuttling transcriptional regulators that are non-DNA binding
    Min M. Lu, Mary R. Muers, Xin Lü · 2016 · Nature Reviews Molecular Cell Biology
80. BET bromodomain is a novel regulator of TAZ and its activity
    Qiong Duan, Yi Xiao, Lingyan Zhu, Zhenzhen Liu, Xiaoxiao Mao, Zhengxiang Zhou, Chaonan Liao, Jinxing Cai, Fulian Huang, Zehao Liu et al. · 2016 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
81. Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets
    Sean R. Porazinski, Michael Ladomery · 2018 · Genes
82. Etv2 transcriptionally regulates Yes1 and promotes cell proliferation during embryogenesis
    Bhairab N. Singh, Wuming Gong, Satyabrata Das, Joshua W. M. Theisen, Javier E. Sierra-Pagán, Demetris Yannopoulos, Erik Skie, Pruthvi Shah, Mary G. Garry, Daniel J. Garry · 2019 · Scientific Reports
83. RASSF6 Is Downregulated In Human Bladder Cancers And Regulates Doxorubicin Sensitivity And Mitochondrial Membrane Potential Via The Hippo Signaling Pathway
    Shutao Tan, Xiaobo Bian, Bin Wu, Xiaonan Chen · 2019 · OncoTargets and Therapy
84. MiR-133 Targets YES1 and Inhibits the Growth of Triple-Negative Breast Cancer Cells
    Guochen Zhang, Junlan Wang, Ruilin Zheng, Beibei Song, Li Huang, Yujiang Liu, Yating Hao, Xiangdong Bai · 2020 · Technology in Cancer Research & Treatment
85. ATF3 Suppresses Growth and Metastasis of Clear Cell Renal Cell Carcinoma by Deactivating EGFR/AKT/GSK3β/β-Catenin Signaling Pathway
    Shenglin Gao, Lei Gao, Simin Wang, Xiaokai Shi, Chuang Yue, Shuzhang Wei, Li Zuo, Lifeng Zhang, Xihu Qin · 2021 · Frontiers in Cell and Developmental Biology
86. YAP/TAZ-associated cell signaling – at the crossroads of cancer and neurodevelopmental disorders
    Aderonke O. Ajongbolo, Sigrid A. Langhans · 2025 · Frontiers in Cell and Developmental Biology
87. Using Large-Scale Genomics Data to Identify Driver Mutations in Lung Cancer: Methods and Challenges
    Andrew Hudson, Christopher Wirth, Natalie L. Stephenson, Shameem Fawdar, John Brognard, Crispin J. Miller · 2015 · Pharmacogenomics
88. The role of YAP in the control of the metastatic potential of oral cancer
    Usama Sharif Ahmad, KARTHIK SARAVANAN, Hong Wan · 2021 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
89. TPX2 prompts mitotic survival via the induction of BCL2L1 through YAP1 protein stabilization in human embryonic stem cells
    Yun Kim, Y. Go, Ho-Chang Jeong, Eun-Ji Kwon, S. Kim, H. Cheong, Wantae Kim, H. Shin, Haeseung Lee, Hyuk-Jin Cha · 2023 · Experimental and Molecular Medicine
90. Relationship between regulatory pattern of gene expression level and gene function
    Masayo Inoue, Katsuhisa Horimoto · 2017 · PLoS ONE
91. Cyclic pulsation stress promotes bone formation of tissue engineered laminae through the F-actin/YAP-1/β-Catenin signaling axis
    Linli Li, Hailong Li, Yiqun He, Han Tang, Jian Dong, Xujun Chen, Feizhou Lyu, Youhai Dong · 2021 · npj Regenerative Medicine
92. SRC Family Kinase Inhibition Targets YES1 and YAP1 as Primary Drivers of Lung Cancer and as Mediators of Acquired Resistance to ALK and Epidermal Growth Factor Receptor Inhibitors
    Hiroki Sato, Daisuke Kubota, Huan Qiao, Achim A. Jungbluth, Natasha Rekhtman, Adam Jacob Schoenfeld, Helena Alexandra Yu, Gregory J. Riely, Shinichi Toyooka, Christine Marie Lovly et al. · 2022 · JCO Precision Oncology
93. Adjuvant Effects of L. acidophilus LW1 on Immune Responses to the Foot-and-Mouth Disease Virus DNA Vaccine in Mice
    Junhong Su, Jidong Li, Haixue Zheng, Yanan You, Xuenong Luo, Yungang Li, Xueqiang Li, Xusheng Ma, Junjun Li, Yongxi Dou et al. · 2014 · PLoS ONE
94. Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations
    Ander Aramburu, Isabel Zudaire, Maria Jose Pajares, Jackeline Agorreta, Alberto Orta, María D. Lozano, Alfonso Gúrpide, Javier Gómez‐Román, Jose Angel Martinez-Climent, Jacek Jassem et al. · 2015 · BMC Genomics
95. Addiction to multiple oncogenes can be exploited to prevent the emergence of therapeutic resistance
    Peter S. Choi, Yulin Li, Dean W. Felsher · 2014 · Proceedings of the National Academy of Sciences
96. β‐catenin regulates IRF3‐mediated innate immune signalling in colorectal cancer
    Chengming Ding, Jun He, Jun Zhao, Junhua Li, Jie Chen, Wenyan Liao, Yi Arial Zeng, Jing Zhong, Chaoying Wei, Liming Zhang et al. · 2018 · Cell Proliferation
97. Hippo/YAP signaling’s multifaceted crosstalk in cancer
    Jie Zhang, Haipeng Wu, Xinxin Ren, Zhuoshi Chen, Siyu Ye, Shuchang Chen, Jie Fang, Qirou Wu, Tiejun Zhao · 2025 · Frontiers in Cell and Developmental Biology
98. Hippo Pathway Regulation by Tyrosine Kinases
    Nina Bacher Reuven, Matan Shanzer, Yosef Shaul · 2018 · Methods in molecular biology
99. Src mediates β-adrenergic receptor induced YAP tyrosine phosphorylation
    Wenjing Wang, Wenqi Li, Kai Liu, Xiaodou Niu, Kaihang Guan, Yunqi Jiang, Zijian Li, Erdan Dong · 2020 · Science China Life Sciences
100. Asparagine Synthetase Marks a Distinct Dependency Threshold for Cardiomyocyte Dedifferentiation
     Yike Zhu, Matthew Andrew Ackers-Johnson, Muthu Kumaraswamy Shanmugam, Leroy Sivappiragasam Pakkiri, Chester Lee Drum, Yanpu Chen, Johnny Kim, Wyatt G. Paltzer, Ahmed I. Mahmoud, Wilson Lek Wen Tan et al. · 2024 · Circulation